全文获取类型
收费全文 | 1045篇 |
免费 | 95篇 |
国内免费 | 19篇 |
专业分类
儿科学 | 77篇 |
妇产科学 | 4篇 |
基础医学 | 128篇 |
口腔科学 | 63篇 |
临床医学 | 121篇 |
内科学 | 181篇 |
皮肤病学 | 46篇 |
神经病学 | 27篇 |
特种医学 | 241篇 |
外科学 | 78篇 |
综合类 | 34篇 |
预防医学 | 54篇 |
眼科学 | 13篇 |
药学 | 29篇 |
1篇 | |
肿瘤学 | 62篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 6篇 |
2020年 | 9篇 |
2019年 | 8篇 |
2018年 | 14篇 |
2017年 | 6篇 |
2016年 | 12篇 |
2015年 | 27篇 |
2014年 | 23篇 |
2013年 | 41篇 |
2012年 | 22篇 |
2011年 | 20篇 |
2010年 | 53篇 |
2009年 | 52篇 |
2008年 | 22篇 |
2007年 | 33篇 |
2006年 | 23篇 |
2005年 | 25篇 |
2004年 | 15篇 |
2003年 | 27篇 |
2002年 | 21篇 |
2001年 | 19篇 |
2000年 | 5篇 |
1999年 | 22篇 |
1998年 | 81篇 |
1997年 | 77篇 |
1996年 | 60篇 |
1995年 | 52篇 |
1994年 | 37篇 |
1993年 | 45篇 |
1992年 | 7篇 |
1991年 | 23篇 |
1990年 | 14篇 |
1989年 | 42篇 |
1988年 | 35篇 |
1987年 | 25篇 |
1986年 | 18篇 |
1985年 | 18篇 |
1984年 | 9篇 |
1983年 | 12篇 |
1982年 | 14篇 |
1981年 | 14篇 |
1980年 | 15篇 |
1979年 | 3篇 |
1978年 | 13篇 |
1977年 | 11篇 |
1976年 | 11篇 |
1975年 | 8篇 |
1961年 | 2篇 |
排序方式: 共有1159条查询结果,搜索用时 218 毫秒
131.
Eosinophil functions can be modulated by several cytokines such as granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin- 3 (IL-3), and IL-5. We have investigated the modulatory role of these cytokines on the interaction of human eosinophils with opsonized particles (serum-treated zymosan [STZ]). Addition of STZ to eosinophils isolated from the peripheral blood of normal human donors resulted in an interaction of the STZ particles with only 15% to 25% of the cells. Treatment of the eosinophils with GM-CSF, IL-3, or IL-5 strongly enhanced both the rate of particle binding and the percentage of eosinophils binding STZ. The effect of the cytokines is most likely mediated by a change in affinity of the complement receptor type 3 (CR3) on the eosinophils for the complement fragment iC3b on the STZ particles. This is indicated by the observation that (1) the effect of the cytokines on STZ binding was prevented by a monoclonal antibody against the iC3b-binding site on CR3 and (2) the enhanced binding was already apparent before upregulation of CR3 on the cell surface was observed. In a previous study, similar results were obtained with platelet-activating factor (PAF)-primed eosinophils. Because we found that the cytokines strongly enhanced the STZ-induced PAF synthesis, we investigated the role of both released PAF and cell-associated PAF in the priming phenomenon by the cytokines. Cytokine priming appeared to be largely independent of the synthesis of PAF. 相似文献
132.
Jessurun GA Hautvast RW DeJongste MJ Meyler WJ van Boven AJ Crijns HJ 《The Journal of invasive cardiology》1999,11(7):435-438
Patients with symptomatic small vessel coronary artery disease may be inadequate candidates for revascularization procedures. They may suffer from refractory angina, which does not respond to maximal anti-anginal drug therapy. In addition to patients with end stage coronary artery disease and syndrome X, this newly defined group of subjects with an isolated stenosis of a small coronary artery may benefit from electrical neurostimulation. We describe two patients with intractable angina caused by a significant narrowing of a diagonal branch. This treatment modality should be considered as an alternative method for unsatisfactory revascularization procedures. 相似文献
133.
Expression of bcl-xL can confer a multidrug resistance phenotype 总被引:14,自引:3,他引:14
It has been suggested that genes that regulate apoptotic cell death may play an important role in determining the sensitivity of tumor cells to chemotherapy. We have recently cloned a member of the bcl-2 family, bcl- x. To test whether bcl-XL expression affects the sensitivity of tumor cells to chemotherapy, we have created stable cell lines overexpressing bcl-XL and have tested these cells for resistance to cell death induced by metabolic inhibitors and chemotherapeutic agents. Bcl-XL expression dramatically reduces the cytotoxicity of bleomycin, cisplatin, etoposide, vincristine, hygromycin B, and mycophenolic acid for up to 4 days in culture. Bcl-XL does not prevent cells from undergoing cell cycle arrest in response to these drugs, but rather prevents treated cells from undergoing apoptosis. Cell-cycle analysis on cells treated with the chemotherapeutic agents bleomycin, cisplatin, etoposide, and vincristine, show that the drugs cause growth arrest in different positions within the cell cycle. Bcl-XL expressing cells treated with chemotherapeutic drugs retain their proliferative ability after the drugs are removed. Interestingly, vincristine-treated cells expressing bcl-XL become polyploid after drug removal. These data show that bcl-XL protects cells from a wide variety of apoptotic stimuli, acts in multiple positions within the cell cycle, and confers a multidrug resistance phenotype. The ability of bcl-XL to prevent apoptotic cell death in response to chemotherapy-induced DNA damage and cell-cycle arrest may contribute to the accumulation of chromosomal aberrations within tumors. The expression of bcl-XL in tumor cells is likely to be an important indicator of chemotherapeutic efficacy. 相似文献
134.
Stephens RW; Golder JP; Fayle DR; Hume DA; Hapel AJ; Allan W; Fordham CJ; Doe WF 《Blood》1985,66(2):333-337
Adherent monolayer cultures of human blood monocytes, peritoneal macrophages, bone marrow macrophages, and colonic mucosa macrophages were examined for their ability to produce and secrete minactivin, a specific inactivator of urokinase-type plasminogen activator. All except colonic mucosa macrophages produced and secreted appreciable amounts of minactivin, but only blood monocytes were stimulated by muramyl dipeptide (adjuvant peptide) to increase production. The minactivin from each of these populations could be shown to preferentially inhibit urokinase-type plasminogen activator and not trypsin, plasmin, or "tissue"-type plasminogen activator (HPA66). A plasminogen-activating enzyme present in monocyte cultures appeared unaffected by the presence of minactivin and could be shown to be regulated independently by dexamethasone. 相似文献
135.
The purpose of the present study was to investigate a possible seasonal
pattern in various clinical and laboratory manifestations in a group of
systemic lupus erythamatosus (SLE) patients. One hundred and five SLE
patients were followed up during a 4 yr period. Data on each of the
clinical and laboratory variables examined, as well as the results of the
disease activity index (SLEDAI), were plotted against the month during
which they were obtained. Photosensitivity was the only variable to show a
seasonal pattern, having higher scores during the summer months (1.04 +/-
0.16 in July vs 0.58 +/- 0.12 in December). We were unable to show seasonal
patterns in any of the other variables examined. As a group, SLE patients
do not show any significant seasonal pattern in disease manifestations and
activity, except for photosensitivity. However, such a pattern may exist
for the individual patient.
相似文献
136.
An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1) 总被引:21,自引:7,他引:21
A variant subline (KG-1a) of the human acute myelogenous leukemia (AML) cell line (KG-1) has been isolated. The cells retain the same constitutive markers as the parent line, including HLA antigens, isoenzymes, and karyotype. The cells from the subline are morphologically and histochemically undifferentiated blast cells, while the parent cells and several of its clones are at the myeloblast and promyelocyte stages of development. The variant cells do not respond to colony-stimulating factor (CSF), and they do not express the human la antigen, nor a recently characterized AML antigen. The parent KG-1 cells are stimulated to proliferate in the presence of CSF and the cells express the la and AML antigen. Variant AML cell lines, such as KG-1a, will be useful in vitro models for investigating cellular response to CSF and for studying antigen expression in leukemic cells. 相似文献
137.
138.
RG Lee K Nakamura AC Tsamandas K Abu-Elmagd H Furukawa WR Hutson J Reyes JS Tabasco-Minguillan S Todo AJ Demetris 《Gastroenterology》1996,110(6):1820-1834
BACKGROUND & AIMS: Intestinal transplantation is a developing therapeutic option for patients with irreversible intestinal failure or short bowel syndrome. The aim of this study was to delineate the histopathology of human intestinal allografts and to define the features of intestinal rejection. METHODS: The histological features of 3015 endoscopic biopsy specimens and 23 allograft specimens from 62 intestinal recipients were analyzed retrospectively and correlated with clinical findings. RESULTS: Acute allograft rejection was characterized by a varying combination of crypt injury, mucosal infiltration primarily by mononuclear cells (including blastic lymphocytes), and increased crypt cell apoptosis (more than 2 per 10 crypts). It represented a patchy, often ileal-centered process that could progress to mucosal ulceration; later episodes (more than 100 days posttransplant) tended to show lesser cellular infiltration and greater apoptosis than earlier episodes. Correlation with clinical rejection was good (false-positive rate of 9%; false-negative rate of 26%). Two resected specimens showed obliterative arteriopathy indicative of chronic rejection. In other specimens, preservation injury, cytomegalovirus infection, post-transplant lymphoproliferative disorder, and nonspecific features of active or past mucosal injury could be recognized. CONCLUSIONS: Mucosal biopsy specimens are a useful means of monitoring intestinal allografts. Based on features validated by clinical correlation, acute rejection can be identified reliably and can be differentiated from the other pathological processes affecting the intestinal allograft. (Gastroenterology 1996 Jun;110(6):1820-34) 相似文献
139.
140.